Nabriva Therapeutics plc
NBRVF----
Forecast & RatingOnly 1 analyst currently covers Nabriva Therapeutics plc (NBRVF.US), with a price target of $1.00 and a rating of "Underweight". The sample is very small, so treat this as a reference only. Data as of Jan 6, 2026; this does not constitute investment advice.
Mar 27, 2023Price forecast
$1.00999900.00%
Forecast & RatingSell
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell100.00%
Target price forecast
No data available at the moment
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.